Biomarkers for immunotherapy of cancer : (Record no. 653957)

MARC details
000 -LEADER
fixed length control field 08171cam a2200757 i 4500
001 - CONTROL NUMBER
control field on1120771681
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250702171152.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cnu||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 190924s2020 nyua ob 001 0 eng
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Description conventions rda
-- pn
Transcribing agency NLM
Modifying agency UKMGB
-- OCLCF
-- SCB
-- GW5XE
-- OCLCO
-- OCLCA
-- OCLCQ
-- OCLCA
-- OCLCO
-- OCL
-- OCLCO
-- OCLCA
-- OCLCL
015 ## - NATIONAL BIBLIOGRAPHY NUMBER
National bibliography number GBB9G3423
Source bnb
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER
Record control number 101774071
Source DNLM
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER
Record control number 019543116
Source Uk
019 ## -
-- 1122163217
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781493997732
Qualifying information (eBook)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1493997734
Qualifying information (eBook)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9781493997725
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/978-1-4939-9773-2
Source of number or code doi
029 0# - (OCLC)
OCLC library identifier NLM
System control number 101774071
029 1# - (OCLC)
OCLC library identifier UKMGB
System control number 019543116
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)1120771681
Canceled/invalid control number (OCoLC)1122163217
037 ## - SOURCE OF ACQUISITION
Stock number com.springer.onix.9781493997732
Source of stock number/acquisition Springer Nature
042 ## - AUTHENTICATION CODE
Authentication code pcc
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC271.I45
Item number B56 2020eb
060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number W1
Item number ME9616J v.2055 2020
060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QZ 25
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.99/406
Edition number 23
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
245 00 - TITLE STATEMENT
Title Biomarkers for immunotherapy of cancer :
Remainder of title methods and protocols /
Statement of responsibility, etc. edited by Magdalena Thurin, Alessandra Cesano, Francesco M. Marincola.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture New York :
Name of producer, publisher, distributor, manufacturer Humana Press,
Date of production, publication, distribution, manufacture, or copyright notice [2020]
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (1 PDF file (xviii, 733 pages)) :
Other physical details illustrations
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
490 1# - SERIES STATEMENT
Series statement Methods in molecular biology,
International Standard Serial Number 1940-6029 ;
Volume/sequential designation v. 2055
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Part I: Scientific Questions and the Status of Inhibitory Receptors for Immunotherapy 1. Status of Immune-oncology: Challenges and Opportunities Alessandra Cesano, Francesco M Marincola, and Magdalena Thurin 2. Immunological Targets for Immunotherapy: Inhibitory T Cell Receptors Diwakar Davar and Hassane M. Zarour Part II : Mutational and Germline Profiling 3. Measuring Tumor Mutational Burden Using Whole Exome Sequencing Tomas Vilimas 4. Germline Genetics in Immuno-Oncology: From Genome-wide to Targeted Biomarker Strategies Tomas Kirchhoff and Robert Ferguson 5. Detection of Microsatellite Instability Biomarkers via Next-generation Sequencing Russell Bonneville, Melanie A. Krook, Hui-Zi Chen, Amy Smith, Eric Samorodnitsky, Michele R. Wing, Julie W. Reeser, and Sameek Roychowdhury 6. Genetic Instability Markers in Cancer Giuseppe Palmieri, Milena Casula, Antonella Manca, Grazia Palomba, Maria Cristina Sini, Valentina Doneddu, Antonio Cossu, and Maria Colombino 7. Validation of Circulating Tumor DNA Assays for Detection of Metastatic Melanoma Mahrukh M Syeda, Jennifer M. Wiggins, Broderick Corless, Cindy Spittle, George Karlin-Neumann, and David Polsky 8. Techniques Associated with Exosome Isolation for Biomarker Development -- Liquid Biopsies for Ovarian Cancer Detection Shayna Sharma and Carlos Salomon Part III: Epigenetic Profiling 9. Identifying MicroRNA Pathway Variants as Biomarkers of Patient Selection for Immune Therapy Joanne B. Weidhaas 10. Histone Modifications as Biomarkers for Immunotherapy Erin M. Taylor, Brian Koss, Lauren E. Davis, and Alan J. Tackett Part IV: Functional Genomic Profiling 11. Functional Genome Profiling to Understand Cancer Immune Responsiveness Ena Wang, Davide Bedognetti, and Francesco M Marincola 12. Using RNA-sequencing to Characterize the Tumor Microenvironment Smith CC, Bixby LM, Miller KL, Selitsky SR, Bortone DS, Hoadley KA, Vincent BG, and Serody JS 13. Development of Gene Expression Based Biomarkers on the nCounter® Platform for Immuno-Oncology Applications Sarah Warren, Patrick Danaher, Afshin Mashadi-Hossein, Lynell Skewis, Brett Wallden, Sean Ferree, and Alessandra Cesano 14. The CRISPR System and Cancer Immunotherapy Biomarkers Vitaly Balan and Jianbin Wang Part V: Phenotyping of Tumor and Immune Cells 15. HLA Class I Antigen Processing Machinery Defects in Cancer Cells -- Frequency, Functional Significance and Clinical Relevance with Special Emphasis on their Role in T cell-based Immunotherapy of Malignant Disease Barbara Seliger and Soldano Ferrone 16. High-parameter Immune Profiling with CyTOF Bita Sahaf, Adeeb Rahman, Holden T. Maecker, and Sean Bendall 17. The Adaptome as Biomarker for Assessing Cancer Immunity and Immunotherapy Jian Han and Michael T. Lotze 18. Single Molecule Arrays for Ultrasensitive Detection of Blood-based Biomarkers for Immunotherapy Limor Cohen, Alissa Keegan, and David R Walt 19. Single-cell Multiplexed Proteomics on the IsoLight Resolves Cellular Functional Heterogeneity to Reveal Clinical Responses of Cancer Patients to Immunotherapies Dong Liu, Patrick Paczkowski, Sean Mackay, Colin Ng, and Jing Zhou 20. Methods to Detect Immunogenic Cell Death in vivo Takahiro Yamazaki, Aitziber Buqué Martinez, Marissa Rybstein, Jonathan Chen, Ai Sato, and Lorenzo Galluzzi Part VI: Tissue Imaging Methods 21. Overview of Tissue Imaging Methods Sanjay S. Patel and Scott J. Rodig 22. Multiplex Immunofluorescence Assays Alejandro Francisco-Cruz, Edwin Roger Parra, Michael T. Tetzlaff, and Ignacio I. Wistuba, 23. Multiplexed Immunohistochemical Consecutive Staining on Single Slide (MICSSS): Multiplexed Chromogenic IHC Assay for High-Dimensional Tissue Analysis Guray Akturk, Robert Sweeney, Romain Remark, Miriam Merad, and Sacha Gnjatic 24 Cyclic Multiplexed-Immunofluorescence (cmIF), A Highly Multiplexed Method for Single-cell Analysis Jennifer Eng, Guillaume Thibault, Shiuh-Wen Luoh, Joe W. Gray, Young Hwan Chang, and Koei Chin 25. High-Plex Spatially Resolved RNA and Protein Detection using Digital Spatial Profiling: A Technology Designed for Immuno-Oncology Biomarker Discovery and Translational Research Joseph M. Beechem 26. The InSituPlex® Staining Method for Multiplexed Immunofluorescence Cell Phenotyping and Spatial Profiling of Tumor FFPE Samples Mael Manesse, Katir K. Patel, Sean R. Downing, and Mark Bobrow Part VII: Microbiome 27. Microbiome as an Immunological Modifier Manoj Kumar, Parul Singh, Selvasankar Murugesan, Marie Vetizou, John McCulloch, Jonathan H. Badger, Giorgio Trinchieri, and Souhaila Al Khodor Part VIII: System Biology for Multi-platform Data Integration 28. Systems Biology for Multi-Platform Data Integration -- Overview Elad Ziv 29. Bioinformatics Tools and Resources for Cancer Immunotherapy Study Alida Palmisano, Julia Krushkal, Ming-Chung Li, Jianwen Fang, Dmitriy Sonkin, George Wright, Laura Yee, Yingdong Zhao, Lisa McShane 30. Multiplatform Integrative Analysis of Immunogenomic Data for Biomarker Discovery Vésteinn Thorsson Part IX: Regulatory Perspective 31. Translating Immuno-Oncology Biomarkers to Diagnostic tests: A Regulatory Perspective You Li, Janaki Veeraraghavan, and Reena Philip.
588 0# - SOURCE OF DESCRIPTION NOTE
Source of description note Online resource; title from PDF title page (SpringerLink, viewed January 25, 2021).
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Cancer
General subdivision Immunotherapy.
9 (RLIN) 82551
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Biochemical markers.
9 (RLIN) 83885
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Tumor markers.
9 (RLIN) 82318
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Neoplasms
General subdivision therapy
9 (RLIN) 80620
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Immunotherapy
General subdivision methods
9 (RLIN) 82558
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Biomarkers, Tumor
9 (RLIN) 82324
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Computational Biology
General subdivision methods
9 (RLIN) 2073
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Biomarkers.
9 (RLIN) 83769
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Cancer
General subdivision Immunothérapie.
9 (RLIN) 84050
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Marqueurs biologiques.
9 (RLIN) 83891
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Marqueurs tumoraux.
9 (RLIN) 82325
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Tumor markers
Source of heading or term fast
9 (RLIN) 82318
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Biochemical markers
Source of heading or term fast
9 (RLIN) 83885
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Cancer
General subdivision Immunotherapy
Source of heading or term fast
9 (RLIN) 82551
655 #2 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Laboratory Manual
655 #7 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Laboratory manuals
Source of term fast
655 #7 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Laboratory manuals.
Source of term lcgft
655 #7 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Manuels de laboratoire.
Source of term rvmgf
9 (RLIN) 966128
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Thurin, Magdalena,
Relator term editor.
9 (RLIN) 89321
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cesano, Alessandra,
Relator term editor.
9 (RLIN) 95236
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Marincola, Francesco M.,
Relator term editor.
9 (RLIN) 89322
758 ## -
-- has work:
-- Biomarkers for immunotherapy of cancer (Text)
-- https://id.oclc.org/worldcat/entity/E39PCFBbxkCKXm3Hc8x86vr8qP
-- https://id.oclc.org/worldcat/ontology/hasWork
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Methods in molecular biology (Clifton, N.J.) ;
Volume number/sequential designation v. 2055.
International Standard Serial Number 1064-3745
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://link-springer-com.libraryproxy.ist.ac.at/10.1007/978-1-4939-9773-2">https://link-springer-com.libraryproxy.ist.ac.at/10.1007/978-1-4939-9773-2</a>
994 ## -
-- 92
-- ATIST
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection code Home library Current library Date acquired Total Checkouts Date last seen Price effective from Koha item type
  Not Lost     eBook Protocols e-Library e-Library 03/08/2022   03/08/2022 03/08/2022 eBook

Powered by Koha